Breast cancer risk for transgender men with inherited mutations
https://www.facingourrisk.org/XRAY/breast-cancer-risk-transgender-men-with-inherited-mutations
Full article: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8747588/pdf/gox-10-e4012.pdf
There is little information related to the risks and treatment options for transgender men and nonbinary people who are at high-risk for breast cancer due to an inherited BRCA1 or BRCA2 mutation. We review an expert viewpoint on the implications of a BRCA mutation for transgender men undergoing breast removal as part of their gender-affirming care plan. (posted 5/19/22)
Este artículo está disponible en español.
Questions To Ask Your Health Care Provider
- Not every provider who offers gender-affirming care has experience with the medical concerns of people with a high risk of hereditary cancer, including those who have a BRCA1 or BRCA2 mutation. Likewise, not every surgeon who performs prophylactic mastectomies to address cancer risk is skilled in supporting trans and nonbinary people. Ask if your doctor is able to support you with both of these experiences.
- If you are uncomfortable with mammography, ask if ultrasound or MRI options are available. If you have already completed a gender-affirming top surgery, ask what screening options may be appropriate for your needs.
- Ask if your doctors are familiar with the literature and guidelines that exist for transgender and nonbinary people and cancer care.
Open Clinical Trials
The following studies are specifically enrolling people from the LGBTQ+ community.
- PRIDE Study: The PRIDE Study is the first long-term national health study of LGBTQ+ people. The goal is to improve the long-term health and wellness of LGBTQ+ people.
Visit our Featured Research Page and Research Search and Enroll Tool to find additional studies enrolling people with or at high risk for cancer. Note: Most of these trials are geared towards cisgender people.
About FORCE
FORCE is a national nonprofit organization, established in 1999. Our mission is to improve the lives of individuals and families affected by adult hereditary cancers.